Lockheed Martin Upgraded at Ubs on Missile Growth - Sep 8

The Big Picture

UBS upgraded Lockheed Martin, assigning a $674 price target that implies about 9% upside and saying the stock does not reflect expected missile growth, a development that could influence defense-heavy portfolios.

The upgrade and target highlight renewed analyst attention on $LMT after concerns that shares are not pricing in strong earnings growth, according to UBS.

What's Happening

UBS issued an upgrade on Lockheed Martin and backed the call with a specific price target and upside estimate. Here are the core data points investors should track:

• Date of coverage cited: Sep 8, 2026
• UBS price target: $674
• Implied upside from the target: roughly 9%
• Analyst thesis: UBS says shares do not appear to be pricing in strong earnings growth

The firm’s note frames missile business growth as underappreciated by the market, which is the main catalyst behind the upgrade. UBS’s view contrasts with broader skepticism that may have capped the stock until now.

Why It Matters For Your Portfolio

An upgrade from a major bank like UBS can alter sentiment, trigger re-rating trades, and push other analysts to revisit assumptions about defense revenues. Growth investors will watch for acceleration in missile-related revenue, while value-oriented portfolios may reassess upside based on the $674 target.

Traders may see increased volatility as the market digests the upgrade and looks for confirmation of the thesis in upcoming company and contract news. Analysts note that shares may not yet reflect potential earnings momentum, which is why the UBS call is notable for $LMT stakeholders.

Risks To Consider

• Execution risk: If missile revenue growth disappoints, the implied 9% upside may not materialize and the stock could revert to prior levels.
• Market skepticism: The thesis depends on the market changing how it values defense earnings; if sentiment stays cautious, prices may be range-bound despite the upgrade.
• Analyst divergence: Other firms may take different views, creating mixed signals that could increase short-term volatility.

What To Watch Next

Several near-term items could validate or challenge UBS’s thesis. Monitor these catalysts and metrics closely:

• Company commentary and quarterly earnings that reveal missile segment revenue trends
• New contract awards or delivery updates tied to missile programs
• Additional analyst notes or revisions that either reinforce or counter UBS’s $674 target

The Bottom Line

• UBS upgraded $LMT and set a $674 target, implying about 9% upside from current levels, citing underappreciated missile growth.
• The note signals renewed analyst attention, which could prompt re-rating if upcoming results confirm stronger missile-related earnings.
• Risks include execution misses, persistent market skepticism, and divergent analyst views that could keep volatility elevated.
• Investors should track upcoming earnings, contract news, and any follow-up analyst activity to see if UBS’s thesis gains traction.

FAQ

Q: What did UBS say about Lockheed Martin?

A: UBS upgraded Lockheed Martin and argued the stock underprices missile growth, assigning a $674 target that implies roughly 9% upside.

Q: How should I interpret the $674 target and 9% figure?

A: The $674 target is UBS’s view of fair value based on its analysis; the 9% figure represents the implied upside from the target relative to current trading levels referenced in the note.

Q: What are the next signs that would validate UBS’s thesis?

A: Look for stronger-than-expected missile-segment revenue in company reports, major contract awards tied to missile programs, and corroborating analyst revisions that raise estimates or targets.